Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2379 (LINC02379) is a human gene that encodes a long non-coding RNA transcript greater than 200 nucleotides and does not overlap with annotated protein-coding genes. LINC02379 belongs to the family of long intergenic non-coding RNAs (lincRNAs), which represent a major class of non-coding RNAs involved in diverse cellular processes such as chromatin modification and gene expression regulation, though only a small subset of lincRNAs have well-defined functional annotations. There are no experimentally validated biological functions, disease associations, or drug interactions currently ascribed to LINC02379. Its biological significance remains to be determined.
None known
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2379 (LINC02379).